Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis.

Trial Profile

Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Apr 2012

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Azithromycin (Primary) ; Amoxicillin/clavulanic acid
  • Indications Acute sinusitis; Bacterial infections
  • Focus Therapeutic Use
  • Acronyms EASY
  • Sponsors Pfizer

Most Recent Events

  • 09 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 08 Apr 2011 Planned end date changed from 1 Feb 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
  • 13 Oct 2010 Planned end date changed from 1 Aug 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top